Table 3.
Peanut allergy |
No peanut allergy |
p-value | |
---|---|---|---|
n=52 |
n=190 |
||
n (%) / |
n (%) / |
||
median (IQR) | median (IQR) | ||
Male sex |
33 (63.5) |
124 (65.3) |
0.809 |
Age at IgE measurement (years) |
5.8 (2.8-12.1) |
6.9 (3.8-11.4) |
0.506 |
Primary care |
25 (48.0%) |
127 (66.7%) |
0.013 |
Level of peanut-specific IgE (kU/l) |
14.8 (1.9-88.5) |
1.4 (0.7-5.2) |
<0.001 |
Level of total IgE (kU/L) |
312 (112–1044) |
553 (172–1138) |
0.427 |
History of atopic disease |
49 (94.2) |
181 (95.3) |
0.804 |
- Eczema |
46 (90.2) |
134 (70.5) |
0.004 |
- Asthma |
32 (61.5) |
85 (44.7) |
0.032 |
- Allergic rhinitis |
29 (58.0) |
128 (70.7) |
0.088 |
Family history of allergy |
41 (93.2) |
136 (88.3) |
0.355 |
Good asthma control* | 8 (72.7) | 15 (75.0) | 0.890 |
* ACQ < 1.0 and FEV1 > 80% predicted.
P values represent results of chi squared tests for proportions and Mann–Whitney U test for comparison of medians.